CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
Immune checkpoints represent the system of inhibitory mechanisms regulating the activation of the immune response, preventing the autoimmune processes and modulating the immune response by decreasing the immune cell-mediated damage of tissues and organs. Tumor cells may utilize these checkpoints to...
Guardado en:
Autores principales: | A. V. Bogolyubova, G. A. Efimov, M. S. Drutskaya, S. A. Nedospasov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/803b5b124b054e0eb125b23209da5286 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Monoclonal antibodies in immunodiagnosis and immunotherapy
-
CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
por: Yu. N. Lezhnin, et al.
Publicado: (2018) -
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Antonella Cardinale, et al.
Publicado: (2021) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021) -
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
por: Hannah-Lou Schilling, et al.
Publicado: (2021)